animal models

Psychostimulant-Induced Neuroadaptations in Nucleus Accumbens AMPA Receptor Transmission.

Psychostimulant-Induced Neuroadaptations in Nucleus Accumbens AMPA Receptor Transmission.

Filed under: Addiction Rehab

Cold Spring Harb Perspect Med. 2012 Dec 10;
Pierce RC, Wolf ME

Medium spiny neurons of the nucleus accumbens serve as the interface between corticolimbic regions that… Continue reading

Addiction Rehab: Opioid Addiction in Pregnancy.

Opioid addiction in pregnancy.

Filed under: Addiction Rehab

Obstet Gynecol Surv. 2012 Dec; 67(12): 817-25
Shainker SA, Saia K, Lee-Parritz A

The purpose of this review is to discuss the incidence, risks, pregnancy complications, and maintenance options for treatment… Continue reading

MicroRNAs in Opioid Addiction: Elucidating Evolution.

MicroRNAs in opioid addiction: elucidating evolution.

Filed under: Addiction Rehab

Front Genet. 2012; 3: 241
Wood EJ, Lipovich L

Three reviews in the Frontiers Research Topic “Non-Coding RNA and Addiction” (He and Wang, 2012; Rodriguez, 2012; Zheng et al.,… Continue reading

Evidence for Sustained Elevation of IL-6 in the CNS as a Key Contributor of Depressive-Like Phenotypes.

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

Filed under: Depression Treatment

Transl Psychiatry. 2012; 2: e199
Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, Brandon… Continue reading

Depression Treatment: Importance of the Brain Angiotensin System in Parkinson’s Disease.

Importance of the brain Angiotensin system in Parkinson’s disease.

Filed under: Depression Treatment

Parkinsons Dis. 2012; 2012: 860923
Wright JW, Harding JW

Parkinson’s disease (PD) has become a major health problem affecting 1.5% of the world’s population over 65… Continue reading

Neuromodulation: A More Comprehensive Concept Beyond Deep Brain Stimulation.

Neuromodulation: a more comprehensive concept beyond deep brain stimulation.

Filed under: Addiction Rehab

Int Rev Neurobiol. 2012; 107: 1-3
Hamani C, Moro E

As currently understood, neuromodulation comprises not only electrical and magnetic stimulation but also chemical and genetic… Continue reading

Mindfulness and Bodily Distress.

Mindfulness and bodily distress.

Filed under: Depression Treatment

Dan Med J. 2012 Nov; 59(11): B4547
Fjorback LO

We have created a mindfulness approach to treat patients who experience multiple, persistent, and disabling physical symptoms that cannot be explained by a well-defined medical or surgical condition. Randomized controlled trials in this area are few, and research is hampered by the lack of clear definitions. Bodily distress syndrome (BDS) or bodily stress is an empirically defined definition unifying various conditions such as fibromyalgia, chronic fatigue syndrome, and somatization disorder. In the present PhD, we explored whether patients suffering from BDS may be committed to mental training in the form of mindfulness therapy, which is a mindfulness program specifically targeted patients suffering from BDS. The theoretical model for including mindfulness training in the treatment of BDS is based on identified neurobiological impairments in these patients and the neurobiological improvements that mindfulness training may offer. BDS is a major public health issue possibly associated with the pathology of the immuno-endocrine and autonomic nervous system. BDS patients are often stigmatized, and effective treatment is rarely delivered, which leaves these patients isolated, left by themselves, vulnerable to potentially harming medical and/or alternative treatments. Accordingly, there is a need for non-harming practical tools that patients can learn to master so that they can improve the ability to take responsibility for their own health and wellbeing. Mindfulness-Based Stress Reduction (MBSR) is a group program that employs mindfulness practice to alleviate suffering associated with physical, psychosomatic, and psychiatric disorders. Mindfulness-Based Cognitive Therapy (MBCT) is designed to prevent depressive relapse. Paper I and II present systematic literature reviews only of randomized controlled trials on MBSR and MBCT. The effect of MBSR has been explored on fibromyalgia in three studies, none of them showed convincing results, but gave some indications as to improvement. The reviews recommended MBSR as a useful method for improving mental health; however, lack of long-term follow-up and active control groups are limitations in most studies. MBCT was recommended as a tool for preventing depressive relapse in recovered, recurrently depressed patients, but the implication of MBSR and MBCT is problematic, especially due to the lack of well educated mindfulness teachers. We combined MBSR with cognitive behavioral therapy, CBT, specifically targeted BDS. Paper III provides original data from 119 patients enrolled in a randomized clinical trial, mindfulness therapy for BDS. The randomized controlled trial indicates that BDS patients are capable of and willing to engage in mindfulness therapy. This thesis showed that mindfulness therapy can safely and successfully engage BDS patients in mindfulness practice. Since individual CBT and psychiatric consultation have previously been found to have positive outcomes for BDS patients, we compared mindfulness therapy to an active control group entitled specialized treatment in which an individual treatment was planned in collaboration between the patient and an MD specialized in BDS, CBT, and psychiatry. Mindfulness therapy was comparable to specialized treatment in improving the quality of life and the symptoms of the patients with BDS at 15-month follow-up. For primary outcome physical health (PCS) at 15-month follow-up, different developments over time for the two treatment groups could not be established (F(3,2674) = 1.51, p = 0.21). However, in the mindfulness therapy group, PCS significant changed at the end of treatment and this change remained at 15-month follow-up, whereas no significantly change was seen in the specialized treatment group until at the 15-month follow-up. In the mindfulness therapy group, 26%; CI: 14-38 reported a marked improvement (> 1 SD) at the end of treatment compared with 10%; CI: 2-18 in the specialized treatment group. This amounts to a statistically… Continue reading

Brain-Penetrant Tetrahydronaphthalene Thromboxane A2-Prostanoid (TP) Receptor Antagonists as Prototype Therapeutics for Alzheimer’s Disease.

Brain-Penetrant Tetrahydronaphthalene Thromboxane A2-Prostanoid (TP) Receptor Antagonists as Prototype Therapeutics for Alzheimer’s Disease.

Filed under: Drug and Alcohol Rehabilitation

ACS Chem Neurosci. 2012 Nov 21; 3(11): 928-40
Soper JH, Sugiyama S, Herbst-Robinson K, James MJ, Wang X, Trojanowski JQ,… Continue reading

Addiction Rehab: Involvement of Protein Degradation by the Ubiquitin Proteasome System in Opiate Addictive Behaviors.

Involvement of Protein Degradation by the Ubiquitin Proteasome System in Opiate Addictive Behaviors.

Filed under: Addiction Rehab

Neuropsychopharmacology. 2012 Nov 21;
Massaly N, Dahan L, Baudonnat M, Hovnanian C, Rekik K, Solinas M, David V, Pech S, Zajac JM,… Continue reading

Neurobiological Basis of Dyskinetic Effects Induced by Antipsychotics: The Contribution of Animal Models.

Neurobiological basis of dyskinetic effects induced by antipsychotics: the contribution of animal models.

Filed under: Addiction Rehab

Curr Med Chem. 2012 Nov 13;
Creed MC, Nobrega JN

Tardive dyskinesia (TD) is a movement disorder characterized by abnormal involuntary facial… Continue reading